Literature DB >> 31680596

Sirt3 overexpression alleviates hyperglycemia-induced vascular inflammation through regulating redox balance, cell survival, and AMPK-mediated mitochondrial homeostasis.

Yunfei Wang1, Xue Zhang2, Peng Wang2, Yiting Shen1, Kai Yuan2, Maoran Li2, Wei Liang2, Huafa Que1.   

Abstract

Context: Sirtuin-3 (Sirt3), a NAD-dependent deacetylase, has been reported to be involved in many biological processes.Objective: The present study aimed to investigate the effect and mechanism of Sirt3 on diabetic mice and human umbilical vein endothelial cells (HUVECs) under high glucose (HG) condition.Materials and methods: HUVECs were cultured under HG and inflammation pathway was determined via qPCR, western blots, and immunofluorescence.
Results: Sirt3 expression was reduced in the progression of diabetic nephropathy. Overexpression of Sirt3 sustains renal function and retard the development of diabetic nephropathy. Mechanistically, Sirt3 overexpression attenuated hyperglycemia-mediated endothelial cells apoptosis in kidney. Besides, Sirt3 overexpression repressed oxidative injury and blocked caspase-9-related apoptosis pathway. Moreover, we found that Sirt3 overexpression was associated with AMPK activation and the latter elevates PGC1α-related mitochondrial protective system, especially mitochondrial autophagy. Loss of opa1 and/or inhibition of AMPK could depress mitochondrial autophagy and exacerbates mitochondrial function, finally contributing to the death of human renal mesangial cells.Conclusions: Our results demonstrated the beneficial effects of Sirt3 in the progression of diabetic nephropathy. Increased Sirt3-activated AMPK pathway, augments PGC1α-related mitochondrial protective system, sustained redox balance and closed caspase-9-involved apoptosis pathway in the setting of diabetic nephropathy.

Entities:  

Keywords:  AMPK; PGC1α; Sirt3; caspase-9; cell death; mitochondria

Mesh:

Substances:

Year:  2019        PMID: 31680596     DOI: 10.1080/10799893.2019.1684521

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

Review 1.  SIRT1-SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms.

Authors:  Wenxiu Qi; Cheng Hu; Daqing Zhao; Xiangyan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

2.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

3.  Silencing of PFKFB3 protects podocytes against high glucose‑induced injury by inducing autophagy.

Authors:  Zhengming Zhu; Qingsheng Liu; Jianshi Sun; Ziyang Bao; Weiwei Wang
Journal:  Mol Med Rep       Date:  2021-09-07       Impact factor: 2.952

Review 4.  Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease.

Authors:  Mengdi Wang; Yanyu Pang; Yifan Guo; Lei Tian; Yufei Liu; Cun Shen; Mengchao Liu; Yuan Meng; Zhen Cai; Yuefen Wang; Wenjing Zhao
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

5.  SIRT3 attenuates coronary atherosclerosis in diabetic patients by regulating endothelial cell function.

Authors:  Huiping Gong; Jing Liu; Zhiwei Xue; Wenwen Wang; Cuicui Li; Fanfan Xu; Yimeng Du; Xiaona Lyu
Journal:  J Clin Lab Anal       Date:  2022-07-06       Impact factor: 3.124

Review 6.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14

7.  Sirt3 promotes the autophagy of HK‑2 human proximal tubular epithelial cells via the inhibition of Notch‑1/Hes‑1 signaling.

Authors:  Ying Wang; Jiang Chang; Zi-Qiang Wang; Ying Li
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.